nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—CYP1A2—type 2 diabetes mellitus	0.167	1	CbGaD
Dopamine—DRD5—Bromocriptine—type 2 diabetes mellitus	0.0605	0.104	CbGbCtD
Dopamine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0443	0.076	CbGbCtD
Dopamine—DRD4—Bromocriptine—type 2 diabetes mellitus	0.0431	0.0739	CbGbCtD
Dopamine—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0321	0.0549	CbGbCtD
Dopamine—DRD1—Bromocriptine—type 2 diabetes mellitus	0.0309	0.0529	CbGbCtD
Dopamine—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0266	0.0456	CbGbCtD
Dopamine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0213	0.0365	CbGbCtD
Dopamine—SLC22A3—Metformin—type 2 diabetes mellitus	0.0206	0.0353	CbGbCtD
Dopamine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0188	0.0322	CbGbCtD
Dopamine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0153	0.0261	CbGbCtD
Dopamine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0149	0.0256	CbGbCtD
Dopamine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0136	0.0234	CbGbCtD
Dopamine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.013	0.0222	CbGbCtD
Dopamine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.013	0.0222	CbGbCtD
Dopamine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0127	0.0217	CbGbCtD
Dopamine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0122	0.0209	CbGbCtD
Dopamine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.012	0.0205	CbGbCtD
Dopamine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0116	0.0198	CbGbCtD
Dopamine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.011	0.0189	CbGbCtD
Dopamine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0108	0.0185	CbGbCtD
Dopamine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0108	0.0185	CbGbCtD
Dopamine—SLC22A1—Metformin—type 2 diabetes mellitus	0.0106	0.0182	CbGbCtD
Dopamine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00995	0.0171	CbGbCtD
Dopamine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00986	0.0169	CbGbCtD
Dopamine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00961	0.0165	CbGbCtD
Dopamine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0091	0.0156	CbGbCtD
Dopamine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00879	0.0151	CbGbCtD
Dopamine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0087	0.0149	CbGbCtD
Dopamine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00823	0.0141	CbGbCtD
Dopamine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00817	0.014	CbGbCtD
Dopamine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00784	0.0134	CbGbCtD
Dopamine—DBH—sympathetic nervous system—type 2 diabetes mellitus	0.00758	0.125	CbGeAlD
Dopamine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00748	0.0128	CbGbCtD
Dopamine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00717	0.0123	CbGbCtD
Dopamine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00664	0.0114	CbGbCtD
Dopamine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00607	0.0104	CbGbCtD
Dopamine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00561	0.00961	CbGbCtD
Dopamine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00552	0.00946	CbGbCtD
Dopamine—DBH—autonomic nervous system—type 2 diabetes mellitus	0.0051	0.0841	CbGeAlD
Dopamine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00505	0.00866	CbGbCtD
Dopamine—DBH—peripheral nervous system—type 2 diabetes mellitus	0.00368	0.0607	CbGeAlD
Dopamine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00289	0.0476	CbGeAlD
Dopamine—DBH—nerve—type 2 diabetes mellitus	0.00287	0.0473	CbGeAlD
Dopamine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00278	0.0459	CbGeAlD
Dopamine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00194	0.032	CbGeAlD
Dopamine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00187	0.0309	CbGeAlD
Dopamine—DRD1—nerve—type 2 diabetes mellitus	0.00168	0.0278	CbGeAlD
Dopamine—Azotaemia—Metformin—type 2 diabetes mellitus	0.00164	0.0333	CcSEcCtD
Dopamine—SLC6A3—nerve—type 2 diabetes mellitus	0.00135	0.0223	CbGeAlD
Dopamine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00135	0.0223	CbGeAlD
Dopamine—MAOB—nerve—type 2 diabetes mellitus	0.00118	0.0195	CbGeAlD
Dopamine—Angina pectoris—Repaglinide—type 2 diabetes mellitus	0.00112	0.0227	CcSEcCtD
Dopamine—Ventricular arrhythmia—Irbesartan—type 2 diabetes mellitus	0.00112	0.0226	CcSEcCtD
Dopamine—SLC6A2—nerve—type 2 diabetes mellitus	0.00109	0.018	CbGeAlD
Dopamine—HTR7—artery—type 2 diabetes mellitus	0.00106	0.0175	CbGeAlD
Dopamine—HTR7—nerve—type 2 diabetes mellitus	0.00105	0.0174	CbGeAlD
Dopamine—Masoprocol—IGF1R—type 2 diabetes mellitus	0.00101	0.195	CrCbGaD
Dopamine—MAOA—nerve—type 2 diabetes mellitus	0.00101	0.0166	CbGeAlD
Dopamine—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.001	0.193	CrCbGaD
Dopamine—DRD2—nerve—type 2 diabetes mellitus	0.000995	0.0164	CbGeAlD
Dopamine—HTR7—endothelium—type 2 diabetes mellitus	0.000896	0.0148	CbGeAlD
Dopamine—Angina pectoris—Pioglitazone—type 2 diabetes mellitus	0.000886	0.018	CcSEcCtD
Dopamine—Angina pectoris—Glimepiride—type 2 diabetes mellitus	0.000863	0.0175	CcSEcCtD
Dopamine—Palpitations—Nateglinide—type 2 diabetes mellitus	0.000817	0.0166	CcSEcCtD
Dopamine—Atrial fibrillation—Valsartan—type 2 diabetes mellitus	0.000736	0.0149	CcSEcCtD
Dopamine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000736	0.0121	CbGeAlD
Dopamine—COMT—islet of Langerhans—type 2 diabetes mellitus	0.000734	0.0121	CbGeAlD
Dopamine—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.000722	0.0147	CcSEcCtD
Dopamine—Palpitations—Repaglinide—type 2 diabetes mellitus	0.000707	0.0143	CcSEcCtD
Dopamine—Hypertension—Repaglinide—type 2 diabetes mellitus	0.000691	0.014	CcSEcCtD
Dopamine—Hypertension—Rosiglitazone—type 2 diabetes mellitus	0.000653	0.0132	CcSEcCtD
Dopamine—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.000652	0.0132	CcSEcCtD
Dopamine—SLC22A2—kidney—type 2 diabetes mellitus	0.000647	0.0107	CbGeAlD
Dopamine—Angina pectoris—Gliclazide—type 2 diabetes mellitus	0.000639	0.013	CcSEcCtD
Dopamine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.00063	0.0104	CbGeAlD
Dopamine—DBH—liver—type 2 diabetes mellitus	0.000621	0.0102	CbGeAlD
Dopamine—Atrial fibrillation—Losartan—type 2 diabetes mellitus	0.000596	0.0121	CcSEcCtD
Dopamine—COMT—nephron tubule—type 2 diabetes mellitus	0.000591	0.00975	CbGeAlD
Dopamine—Nausea—Miglitol—type 2 diabetes mellitus	0.000591	0.012	CcSEcCtD
Dopamine—Hypertension—Glipizide—type 2 diabetes mellitus	0.000571	0.0116	CcSEcCtD
Dopamine—Anxiety—Glipizide—type 2 diabetes mellitus	0.000562	0.0114	CcSEcCtD
Dopamine—Headache—Tolbutamide—type 2 diabetes mellitus	0.000561	0.0114	CcSEcCtD
Dopamine—Hypertension—Pioglitazone—type 2 diabetes mellitus	0.000547	0.0111	CcSEcCtD
Dopamine—Palpitations—Glimepiride—type 2 diabetes mellitus	0.000546	0.0111	CcSEcCtD
Dopamine—Angina pectoris—Metformin—type 2 diabetes mellitus	0.000535	0.0109	CcSEcCtD
Dopamine—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000535	0.0109	CcSEcCtD
Dopamine—Hypertension—Glimepiride—type 2 diabetes mellitus	0.000533	0.0108	CcSEcCtD
Dopamine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000532	0.0108	CcSEcCtD
Dopamine—Hypertension—Sitagliptin—type 2 diabetes mellitus	0.000532	0.0108	CcSEcCtD
Dopamine—COMT—cardiovascular system—type 2 diabetes mellitus	0.000531	0.00876	CbGeAlD
Dopamine—Anxiety—Glimepiride—type 2 diabetes mellitus	0.000524	0.0106	CcSEcCtD
Dopamine—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.000522	0.0106	CcSEcCtD
Dopamine—COMT—kidney—type 2 diabetes mellitus	0.00052	0.00857	CbGeAlD
Dopamine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000518	0.0105	CcSEcCtD
Dopamine—COMT—pancreas—type 2 diabetes mellitus	0.000516	0.00851	CbGeAlD
Dopamine—Atrial fibrillation—Ramipril—type 2 diabetes mellitus	0.000511	0.0104	CcSEcCtD
Dopamine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00051	0.0103	CcSEcCtD
Dopamine—Headache—Tolazamide—type 2 diabetes mellitus	0.00051	0.0103	CcSEcCtD
Dopamine—COMT—cortex of kidney—type 2 diabetes mellitus	0.000506	0.00835	CbGeAlD
Dopamine—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.000505	0.0102	CcSEcCtD
Dopamine—Headache—Linagliptin—type 2 diabetes mellitus	0.000505	0.0102	CcSEcCtD
Dopamine—Vomiting—Acarbose—type 2 diabetes mellitus	0.000497	0.0101	CcSEcCtD
Dopamine—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.000492	0.00998	CcSEcCtD
Dopamine—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000487	0.00804	CbGeAlD
Dopamine—Nausea—Tolazamide—type 2 diabetes mellitus	0.000484	0.00981	CcSEcCtD
Dopamine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000484	0.00981	CcSEcCtD
Dopamine—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000482	0.00977	CcSEcCtD
Dopamine—Hypertension—Bromocriptine—type 2 diabetes mellitus	0.000481	0.00976	CcSEcCtD
Dopamine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00048	0.00973	CcSEcCtD
Dopamine—Angina pectoris—Losartan—type 2 diabetes mellitus	0.000475	0.00964	CcSEcCtD
Dopamine—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.000473	0.00959	CcSEcCtD
Dopamine—COMT—adipose tissue—type 2 diabetes mellitus	0.000468	0.00773	CbGeAlD
Dopamine—Nausea—Acarbose—type 2 diabetes mellitus	0.000465	0.00943	CcSEcCtD
Dopamine—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000461	0.00936	CcSEcCtD
Dopamine—MAOB—nephron tubule—type 2 diabetes mellitus	0.00046	0.00759	CbGeAlD
Dopamine—SLC22A1—kidney—type 2 diabetes mellitus	0.000457	0.00754	CbGeAlD
Dopamine—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.00045	0.00742	CbGeAlD
Dopamine—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000449	0.00912	CcSEcCtD
Dopamine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000448	0.00909	CcSEcCtD
Dopamine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000448	0.00908	CcSEcCtD
Dopamine—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.000444	0.00901	CcSEcCtD
Dopamine—SLC22A3—kidney—type 2 diabetes mellitus	0.000437	0.00721	CbGeAlD
Dopamine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000422	0.00857	CcSEcCtD
Dopamine—MAOA—retina—type 2 diabetes mellitus	0.000417	0.00687	CbGeAlD
Dopamine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000415	0.00842	CcSEcCtD
Dopamine—MAOB—cardiovascular system—type 2 diabetes mellitus	0.000413	0.00682	CbGeAlD
Dopamine—DRD2—retina—type 2 diabetes mellitus	0.000412	0.0068	CbGeAlD
Dopamine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000412	0.0068	CbGeAlD
Dopamine—Headache—Repaglinide—type 2 diabetes mellitus	0.000409	0.0083	CcSEcCtD
Dopamine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000407	0.00827	CcSEcCtD
Dopamine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000405	0.00823	CcSEcCtD
Dopamine—MAOB—kidney—type 2 diabetes mellitus	0.000404	0.00667	CbGeAlD
Dopamine—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000404	0.0082	CcSEcCtD
Dopamine—Droxidopa—ADRB3—type 2 diabetes mellitus	0.000398	0.0768	CrCbGaD
Dopamine—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000397	0.00654	CbGeAlD
Dopamine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000395	0.00801	CcSEcCtD
Dopamine—SLC22A3—adipose tissue—type 2 diabetes mellitus	0.000394	0.00649	CbGeAlD
Dopamine—MAOB—cortex of kidney—type 2 diabetes mellitus	0.000394	0.00649	CbGeAlD
Dopamine—MAOA—nephron tubule—type 2 diabetes mellitus	0.000392	0.00647	CbGeAlD
Dopamine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000388	0.00787	CcSEcCtD
Dopamine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000388	0.00787	CcSEcCtD
Dopamine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000387	0.00784	CcSEcCtD
Dopamine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000386	0.00637	CbGeAlD
Dopamine—SLC22A5—retina—type 2 diabetes mellitus	0.000384	0.00633	CbGeAlD
Dopamine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000371	0.00754	CcSEcCtD
Dopamine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000371	0.00752	CcSEcCtD
Dopamine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000369	0.00608	CbGeAlD
Dopamine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000367	0.00745	CcSEcCtD
Dopamine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000367	0.00744	CcSEcCtD
Dopamine—MAOB—adipose tissue—type 2 diabetes mellitus	0.000364	0.00601	CbGeAlD
Dopamine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000364	0.00739	CcSEcCtD
Dopamine—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.000361	0.0698	CrCbGaD
Dopamine—SLC22A5—nephron tubule—type 2 diabetes mellitus	0.000361	0.00596	CbGeAlD
Dopamine—HTR7—kidney—type 2 diabetes mellitus	0.000361	0.00595	CbGeAlD
Dopamine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000357	0.00723	CcSEcCtD
Dopamine—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000352	0.00581	CbGeAlD
Dopamine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000352	0.00715	CcSEcCtD
Dopamine—MAOA—kidney—type 2 diabetes mellitus	0.000345	0.00569	CbGeAlD
Dopamine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000343	0.00697	CcSEcCtD
Dopamine—MAOA—pancreas—type 2 diabetes mellitus	0.000343	0.00565	CbGeAlD
Dopamine—Headache—Glipizide—type 2 diabetes mellitus	0.000338	0.00687	CcSEcCtD
Dopamine—Palpitations—Metformin—type 2 diabetes mellitus	0.000338	0.00686	CcSEcCtD
Dopamine—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000336	0.00554	CbGeAlD
Dopamine—Norepinephrine—ADRB3—type 2 diabetes mellitus	0.000335	0.0646	CrCbGaD
Dopamine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000333	0.00675	CcSEcCtD
Dopamine—Hypertension—Metformin—type 2 diabetes mellitus	0.00033	0.0067	CcSEcCtD
Dopamine—COMT—liver—type 2 diabetes mellitus	0.000328	0.00542	CbGeAlD
Dopamine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000324	0.00658	CcSEcCtD
Dopamine—Nausea—Glipizide—type 2 diabetes mellitus	0.000321	0.00651	CcSEcCtD
Dopamine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000321	0.0065	CcSEcCtD
Dopamine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000319	0.00648	CcSEcCtD
Dopamine—SLC22A5—kidney—type 2 diabetes mellitus	0.000318	0.00524	CbGeAlD
Dopamine—Headache—Glimepiride—type 2 diabetes mellitus	0.000316	0.00641	CcSEcCtD
Dopamine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000315	0.00639	CcSEcCtD
Dopamine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000312	0.00633	CcSEcCtD
Dopamine—MAOA—adipose tissue—type 2 diabetes mellitus	0.000311	0.00513	CbGeAlD
Dopamine—SLC22A5—cortex of kidney—type 2 diabetes mellitus	0.000309	0.0051	CbGeAlD
Dopamine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000306	0.00622	CcSEcCtD
Dopamine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000306	0.0062	CcSEcCtD
Dopamine—Epinephrine—ADRB3—type 2 diabetes mellitus	0.000304	0.0586	CrCbGaD
Dopamine—Palpitations—Losartan—type 2 diabetes mellitus	0.0003	0.00609	CcSEcCtD
Dopamine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000299	0.00608	CcSEcCtD
Dopamine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000298	0.00606	CcSEcCtD
Dopamine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000289	0.00587	CcSEcCtD
Dopamine—SLC22A1—liver—type 2 diabetes mellitus	0.000289	0.00477	CbGeAlD
Dopamine—Methyldopa—ADRA2A—type 2 diabetes mellitus	0.000288	0.0557	CrCbGaD
Dopamine—Anxiety—Losartan—type 2 diabetes mellitus	0.000288	0.00585	CcSEcCtD
Dopamine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000288	0.00584	CcSEcCtD
Dopamine—SLC22A5—adipose tissue—type 2 diabetes mellitus	0.000286	0.00472	CbGeAlD
Dopamine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000285	0.00578	CcSEcCtD
Dopamine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000279	0.00461	CbGeAlD
Dopamine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000278	0.00565	CcSEcCtD
Dopamine—SLC22A3—liver—type 2 diabetes mellitus	0.000276	0.00455	CbGeAlD
Dopamine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000271	0.00549	CcSEcCtD
Dopamine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00027	0.00548	CcSEcCtD
Dopamine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000264	0.00536	CcSEcCtD
Dopamine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000263	0.00533	CcSEcCtD
Dopamine—Headache—Glyburide—type 2 diabetes mellitus	0.00026	0.00528	CcSEcCtD
Dopamine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000258	0.00523	CcSEcCtD
Dopamine—MAOB—liver—type 2 diabetes mellitus	0.000256	0.00421	CbGeAlD
Dopamine—Levonordefrin—ADRA2A—type 2 diabetes mellitus	0.000255	0.0493	CrCbGaD
Dopamine—Mesalazine—PPARG—type 2 diabetes mellitus	0.000255	0.0492	CrCbGaD
Dopamine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000247	0.00502	CcSEcCtD
Dopamine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000247	0.00502	CcSEcCtD
Dopamine—Nausea—Glyburide—type 2 diabetes mellitus	0.000247	0.00501	CcSEcCtD
Dopamine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000237	0.00482	CcSEcCtD
Dopamine—Headache—Gliclazide—type 2 diabetes mellitus	0.000234	0.00475	CcSEcCtD
Dopamine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000232	0.00471	CcSEcCtD
Dopamine—HTR7—liver—type 2 diabetes mellitus	0.000228	0.00376	CbGeAlD
Dopamine—CYP2C19—liver—type 2 diabetes mellitus	0.000223	0.00367	CbGeAlD
Dopamine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000222	0.0045	CcSEcCtD
Dopamine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000218	0.00442	CcSEcCtD
Dopamine—MAOA—liver—type 2 diabetes mellitus	0.000218	0.0036	CbGeAlD
Dopamine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000215	0.00437	CcSEcCtD
Dopamine—Headache—Valsartan—type 2 diabetes mellitus	0.000215	0.00436	CcSEcCtD
Dopamine—Headache—Orlistat—type 2 diabetes mellitus	0.000212	0.00431	CcSEcCtD
Dopamine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000212	0.0043	CcSEcCtD
Dopamine—CYP2D6—kidney—type 2 diabetes mellitus	0.000205	0.00338	CbGeAlD
Dopamine—Nausea—Valsartan—type 2 diabetes mellitus	0.000204	0.00413	CcSEcCtD
Dopamine—Nausea—Orlistat—type 2 diabetes mellitus	0.000201	0.00408	CcSEcCtD
Dopamine—SLC22A5—liver—type 2 diabetes mellitus	0.000201	0.00331	CbGeAlD
Dopamine—Vomiting—Metformin—type 2 diabetes mellitus	0.000199	0.00403	CcSEcCtD
Dopamine—Headache—Metformin—type 2 diabetes mellitus	0.000196	0.00397	CcSEcCtD
Dopamine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000187	0.0038	CcSEcCtD
Dopamine—Nausea—Metformin—type 2 diabetes mellitus	0.000186	0.00376	CcSEcCtD
Dopamine—Headache—Irbesartan—type 2 diabetes mellitus	0.000185	0.00375	CcSEcCtD
Dopamine—CYP1A2—liver—type 2 diabetes mellitus	0.000182	0.003	CbGeAlD
Dopamine—Droxidopa—ADRA2A—type 2 diabetes mellitus	0.00018	0.0348	CrCbGaD
Dopamine—Vomiting—Losartan—type 2 diabetes mellitus	0.000176	0.00358	CcSEcCtD
Dopamine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000175	0.00355	CcSEcCtD
Dopamine—Headache—Losartan—type 2 diabetes mellitus	0.000174	0.00353	CcSEcCtD
Dopamine—CYP2C9—liver—type 2 diabetes mellitus	0.000173	0.00285	CbGeAlD
Dopamine—Nausea—Losartan—type 2 diabetes mellitus	0.000165	0.00334	CcSEcCtD
Dopamine—Norepinephrine—ADRA2A—type 2 diabetes mellitus	0.000152	0.0293	CrCbGaD
Dopamine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000151	0.00307	CcSEcCtD
Dopamine—Headache—Ramipril—type 2 diabetes mellitus	0.000149	0.00302	CcSEcCtD
Dopamine—Nausea—Ramipril—type 2 diabetes mellitus	0.000141	0.00287	CcSEcCtD
Dopamine—Epinephrine—ADRA2A—type 2 diabetes mellitus	0.000137	0.0265	CrCbGaD
Dopamine—Epinephrine—TNF—type 2 diabetes mellitus	0.00013	0.0252	CrCbGaD
Dopamine—CYP2D6—liver—type 2 diabetes mellitus	0.00013	0.00214	CbGeAlD
Dopamine—Mesalazine—PTGS2—type 2 diabetes mellitus	0.000107	0.0208	CrCbGaD
Dopamine—Norepinephrine—CYP1A2—type 2 diabetes mellitus	0.000105	0.0203	CrCbGaD
Dopamine—Epinephrine—CYP1A2—type 2 diabetes mellitus	9.55e-05	0.0184	CrCbGaD
Dopamine—Epinephrine—CYP3A4—type 2 diabetes mellitus	6.32e-05	0.0122	CrCbGaD
Dopamine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.55e-06	1.89e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.54e-06	1.89e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	2.54e-06	1.89e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.53e-06	1.88e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.53e-06	1.88e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.53e-06	1.88e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.52e-06	1.88e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	2.52e-06	1.88e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.51e-06	1.86e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.49e-06	1.85e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.49e-06	1.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	2.49e-06	1.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	2.49e-06	1.85e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.47e-06	1.84e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.47e-06	1.84e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.47e-06	1.84e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.47e-06	1.83e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.47e-06	1.83e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.46e-06	1.83e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	2.46e-06	1.83e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.46e-06	1.83e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.45e-06	1.82e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.45e-06	1.82e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.45e-06	1.82e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.45e-06	1.82e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.44e-06	1.82e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.43e-06	1.81e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.43e-06	1.81e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.43e-06	1.81e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.43e-06	1.81e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.43e-06	1.8e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.42e-06	1.8e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.41e-06	1.79e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.41e-06	1.79e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.38e-06	1.77e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.36e-06	1.75e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.36e-06	1.75e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.35e-06	1.75e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	2.35e-06	1.75e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.35e-06	1.74e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.34e-06	1.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.34e-06	1.74e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.34e-06	1.74e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.33e-06	1.73e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.33e-06	1.73e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.33e-06	1.73e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.32e-06	1.73e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.32e-06	1.73e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.31e-06	1.72e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.31e-06	1.71e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—AKT1—type 2 diabetes mellitus	2.31e-06	1.71e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.3e-06	1.71e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.29e-06	1.7e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.29e-06	1.7e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.27e-06	1.69e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.27e-06	1.69e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.27e-06	1.69e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.27e-06	1.69e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.26e-06	1.68e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.26e-06	1.68e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.25e-06	1.67e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.25e-06	1.67e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.25e-06	1.67e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.24e-06	1.67e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.23e-06	1.66e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.23e-06	1.66e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.23e-06	1.66e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.23e-06	1.65e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.22e-06	1.65e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.22e-06	1.65e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.22e-06	1.65e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.22e-06	1.65e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.21e-06	1.64e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.2e-06	1.64e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.2e-06	1.63e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.19e-06	1.63e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—AKT1—type 2 diabetes mellitus	2.19e-06	1.62e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.18e-06	1.62e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.17e-06	1.61e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.15e-06	1.6e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.15e-06	1.6e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.14e-06	1.59e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.13e-06	1.58e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	2.12e-06	1.58e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.12e-06	1.58e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.12e-06	1.58e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SRC—type 2 diabetes mellitus	2.12e-06	1.57e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.11e-06	1.57e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.11e-06	1.57e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.11e-06	1.57e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.09e-06	1.56e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.09e-06	1.55e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.09e-06	1.55e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.09e-06	1.55e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.09e-06	1.55e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.08e-06	1.55e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.07e-06	1.54e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.07e-06	1.54e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.06e-06	1.53e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.05e-06	1.53e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.05e-06	1.53e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.05e-06	1.53e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.05e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.04e-06	1.52e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	2.03e-06	1.51e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.03e-06	1.5e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.03e-06	1.5e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.02e-06	1.5e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.01e-06	1.49e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2e-06	1.49e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2e-06	1.48e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.99e-06	1.48e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.98e-06	1.47e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.97e-06	1.47e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.97e-06	1.46e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.96e-06	1.45e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.95e-06	1.45e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.95e-06	1.45e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1.95e-06	1.45e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.94e-06	1.44e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.93e-06	1.44e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.93e-06	1.43e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.93e-06	1.43e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.92e-06	1.43e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.92e-06	1.43e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.92e-06	1.43e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.92e-06	1.42e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.9e-06	1.41e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.89e-06	1.41e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.89e-06	1.41e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.89e-06	1.41e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.89e-06	1.4e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.89e-06	1.4e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.88e-06	1.4e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.87e-06	1.39e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.86e-06	1.38e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-06	1.38e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.86e-06	1.38e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.86e-06	1.38e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.86e-06	1.38e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—IL6—type 2 diabetes mellitus	1.85e-06	1.37e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—AKT1—type 2 diabetes mellitus	1.85e-06	1.37e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.85e-06	1.37e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.84e-06	1.36e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.83e-06	1.36e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.82e-06	1.36e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.82e-06	1.35e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.81e-06	1.35e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.81e-06	1.35e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.8e-06	1.34e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.8e-06	1.34e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.79e-06	1.33e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.79e-06	1.33e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.78e-06	1.32e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.78e-06	1.32e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.78e-06	1.32e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.77e-06	1.32e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.76e-06	1.31e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.75e-06	1.3e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.75e-06	1.3e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.75e-06	1.3e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.75e-06	1.3e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.74e-06	1.29e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.73e-06	1.29e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.73e-06	1.28e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.73e-06	1.28e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.72e-06	1.28e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.72e-06	1.27e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.71e-06	1.27e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.71e-06	1.27e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.71e-06	1.27e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.7e-06	1.26e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.7e-06	1.26e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.68e-06	1.25e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.67e-06	1.24e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.65e-06	1.23e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.64e-06	1.22e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.64e-06	1.22e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.64e-06	1.22e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.63e-06	1.21e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.61e-06	1.2e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.61e-06	1.2e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.6e-06	1.19e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.6e-06	1.19e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.6e-06	1.19e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.58e-06	1.17e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.58e-06	1.17e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.58e-06	1.17e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.57e-06	1.17e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.57e-06	1.17e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.55e-06	1.15e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.53e-06	1.14e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.51e-06	1.12e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.5e-06	1.11e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.5e-06	1.11e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.49e-06	1.11e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.48e-06	1.1e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.48e-06	1.1e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.48e-06	1.1e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.47e-06	1.1e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.47e-06	1.09e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.47e-06	1.09e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.47e-06	1.09e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.45e-06	1.08e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.45e-06	1.08e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.44e-06	1.07e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.43e-06	1.06e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.41e-06	1.05e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.41e-06	1.05e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.4e-06	1.04e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.38e-06	1.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.38e-06	1.02e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	1.37e-06	1.02e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	1.37e-06	1.01e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.36e-06	1.01e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.35e-06	1e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.34e-06	9.97e-06	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.32e-06	9.78e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-06	9.65e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-06	9.65e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.29e-06	9.6e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.29e-06	9.57e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.29e-06	9.57e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.28e-06	9.51e-06	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.26e-06	9.36e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.26e-06	9.32e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.23e-06	9.15e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.23e-06	9.13e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.21e-06	9.01e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.21e-06	8.97e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-06	8.83e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.18e-06	8.75e-06	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.16e-06	8.62e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.15e-06	8.55e-06	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.13e-06	8.42e-06	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.12e-06	8.31e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.11e-06	8.21e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.1e-06	8.18e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.1e-06	8.18e-06	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	1.08e-06	8.03e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.06e-06	7.85e-06	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-06	7.57e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.01e-06	7.48e-06	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.75e-07	7.24e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	9.28e-07	6.89e-06	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.56e-07	6.36e-06	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.49e-07	4.82e-06	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.97e-07	4.44e-06	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	5.92e-07	4.4e-06	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.06e-07	3.76e-06	CbGpPWpGaD
